SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656660.
  • 2
    Kojima M, Hosoda H, Matsuo H, Kangawa K 2001 Ghrelin: Discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 12: 118122.
  • 3
    Bowers CY 1998 Growth hormone-releasing peptide (GHRP). Cell Mol Life Sci 54: 13161329.
  • 4
    Smith RG, Leonard R, Bailey AR, Palyha O, Feighner S, Tan C, Mckee KK, Pong SS, Griffin P, Howard A 2001 Growth hormone secretagogue receptor family members and ligands. Endocrine 14: 914.
  • 5
    Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, De Martino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LH 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273: 974976.
  • 6
    McKee KK, Tan CP, Palyha OC, Liu J, Feighner SD, Hreniuk DL, Smith RG, Howard AD, Van der Ploeg LH 1997 Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors. Genomics 52: 223229.
  • 7
    McKee KK, Palyha OC, Feighner SD, Hreniuk DL, Tan CP, Phillips MS, Smith RG, Van der Ploeg LH, Howard AD 1997 Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors. Mol Endocrinol 11: 415423.
  • 8
    Tschop M, Smiley DL, Heiman ML 2000 Ghrelin induces adiposity in rodents. Nature 407: 908913.
  • 9
    Shuto Y, Shibasaki T, Wada K, Parhar I, Kamegai J, Sugihara H, Oikawa S, Wakabayashu I 2001 Generation of polyclonal antiserum against the growth hormone secretagogue receptor (GHS-R): Evidence that the GHS-R exists in the hypothalamus, pituitary and stomach of rats. Life Sci 68: 991996.
  • 10
    Gualillo O, Caminos JE, Kojima M, Kangawa K, Arvat E, Ghigo E, Casanueva FF, Dieguez C 2001 Gender and gonadal influences on ghrelin mRNA levels in rat stomach. Eur J Endocrinol 44: 687690.
  • 11
    Gaytan F, Barreiro ML, Caminos JE, Chopin LK, Herimgton AC, Morales C, Pinilla L, Paniagua R, Nistal M, Casanueva FF, Aguilar E, Diegez C, Tena-Sempere M 2004 Expression of ghrelin and its functional receptor, the type Ia growth hormone secretagogue receptor, in normal human testis and testicular tumors. J Clin Endocrinol Metab 89: 400409.
  • 12
    Gaytan F, Brreiro ML, Chopin LK, Herington AC, Morales C, Pinilla L, Casanueva FF, Aguilar E, Dieguez C, Tena-Sempere M 2003 Immunolocalization of ghrelin and its functional receptor, the type Ia growth hormone secretagogue receptor, in the cyclic human ovary. J Clin Endocrinol Metab 88: 879887.
  • 13
    Choi K, Roh SG, Hong YH, Shrestha YB, Hishikawa D, Chen C, Kojima M, Kangawa K, Sasaki S 2003 The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology 144: 754759.
  • 14
    Kojima M, Hosoda H, Matsuo H, Kangawa K 2001 Ghrelin: Discovery of the natural endogenous ligand for the growth hormone secretagogue receptor trends. J Clin Endocrinol Metab 12: 118122.
  • 15
    Arvat E, Maccario M, Di Vito L, Broglio F, Benso A, Gottero C, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E 2001 Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: Comparison and interactions with hexaline, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 86: 11691174.
  • 16
    Furuta M, Funabashi T, Kimura F 2001 Intracerebroventricular administration of ghrelin rapidly suppresses pulsatile luteinizing hormone secretion in ovariectomized rats. Biochem Biophys Res Commun 288: 780785.
  • 17
    Okumura H, Nagaya N, Enomoto M, Nakagawa E, Oya H, Kangawa K 2002 Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J Cardiovasc Pharmacol 39: 779783.
  • 18
    Broglio F, Arvat E, Benso A, Papotti M, Muccioli G, Deghenghi R, Ghigo E 2002 Ghrelin: Endocrine and non-endocrine actions. J Pediatr Endocrinol Metab 15: 12191227.
  • 19
    Thompson NM, Gill DA, Davies R, Loveridge N, Houston PA, Robinson IC, Wells T 2004 Endocrinology Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145: 234242.
  • 20
    Olney RC 2003 Regulation of bone mass by growth hormone. Med Pediatr Oncol 41: 228234.
  • 21
    Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC 1998 Growth hormone and bone. Endocr Rev 19: 5579.
  • 22
    Monson JP, Drake WM, Carroll PV, Weaver JU, Rodriguez-Arnao J, Savage MO 2002 Influence of growth hormone on accretion of bone mass. Horm Res 58: 5256.
  • 23
    Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL 1999 Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140: 16301638.
  • 24
    Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, Gordeladze JO, Drevon CA 2001 Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 16: 14261433.
  • 25
    Gordeladze JO, Drevon CA, Syversen U, Reseland JE 2002 Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem 85: 825836.
  • 26
    Cornish J, Callon KE, Bava U, Lin C, Naot D, Hill BL, Grey AB, Broom N, Myers DE, Nicholson GC, Reid IR 2002 Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 175: 405415.
  • 27
    Holloway WR, Collier FM, Aitken CJ, Myers DE, Hodge JM, Malakellis M, Gough TJ, Collier GR, Nicholson GC 2002 Leptin inhibits osteoclast generation. J Bone Miner Res 17: 200209.
  • 28
    Thomas T, Burguera B 2002 Is leptin the link between fat and bone mass? J Bone Miner Res 17: 15631569.
  • 29
    Tamasi JA, Arey BJ, Bertolini DR, Feyen JH 2003 Characterization of bone structure in leptin receptor-deficient Zucker (fa/fa) rats. J Bone Miner Res 18: 16051611.
  • 30
    Horvath TL, Diano S, Sotonyi P, Heiman M, Tschop M 2001 Minireview: Ghrelin and the regulation of energy balance—a hypothalamic perspective. Endocrinology 142: 41634169.
  • 31
    Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K 2001 Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50: 227232.
  • 32
    Okuma S, Kawashima S 1980 Spontaneous dwarf rat. Exp Anim 29: 301.
  • 33
    Bellows CG, Aubin JE, Heersche JN 1987 Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. Endocrinology 121: 19851992.
  • 34
    Naot D, Callon KE, Grey A, Cooper GJ, Reid IR, Cornish J 2001 A potential role for adrenomedullin as a local regulator of bone growth. Endocrinology 142: 18491857.
  • 35
    Date Y, Ueta Y, Yamashita H, Yamaguchi H, Matsukura S, Kangawa K, Sakurai T, Yanagisawa M, Nakazato M 1999 Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci USA 96: 748753.
  • 36
    Dahl LK 1952 A simple and sensitive histochemical method for calcium. Proc Soc Exp Biol Med 80: 474479.
  • 37
    Tschop M, Smiley DL, Heiman ML 2000 Ghrelin induces adiposity in rodents. Nature 407: 908913.
  • 38
    Yamaguchi A, Komori T, Suda T 2000 Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 21: 393411.
  • 39
    Franceschi RT, Xiao G 2003 Regulation of the osteoblast-specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways. J Cell Biochem 88: 446454.
  • 40
    Roelen BA, Dijke P 2003 Controlling mesenchymal stem cell differentiation by TGFBeta family members. J Orthop Sci 8: 740748.
  • 41
    Wells T, Houston PA 2001 Skeletal growth acceleration with growth hormone secretagogues in transgenic growth retarded rats: Pattern-dependent effects and mechanisms of desensitization. J Neuroendocrinol 13: 496504.
  • 42
    Svensson J, Lall S, Dickson SL, Bengtsson BA, Romer J, Ahnfelt-Ronne I, Ohlsson C, Jansson JO 2000 The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. J Endocrinol 165: 569577.
  • 43
    Ishikawa M, Hiroi N, Kamioka T, Tanaka T, Tachibana T, Ishikawa H, Miyachi Y 2001 Metabolic effects of 20 kDa and 22kDa human growth hormones on adult male spontaneous dwarf rats. Eur J Endocrinol 145: 791797.
  • 44
    Wardlaw GM 1996 Putting body weight and osteoporosis into perspective. Am J Clin Nutr 63: 433S436S.
  • 45
    Smith EL, Gilligan C 1996 Dose-response relationship between physical loading and mechanical competence of bone. Bone 18: 455505.
  • 46
    Sun Y, Ahmed S, Smith RG 2003 Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23: 79737981.
  • 47
    Friedman JM, Halaas JL 1998 Leptin and the regulation of body weight in mammals. Nature 395: 763770.
  • 48
    Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G 2002 Leptin regulates bone formation via the sympathetic nervous system. Cell 111: 305317.
  • 49
    Khosla S 2002 Leptin-central or peripheral to the regulation of bone metabolism? Endocrinology 143: 41614164.
  • 50
    Yasuda T, Masaki T, Kakuma T, Yoshimatsu H 2003 Centrally administered ghrelin suppresses sympathetic nerve activity in brown adipose tissue of rats. Neurosci Lett 349: 7578.